surmount-1 tirzepatide non-diabetic obesity weight loss 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO trial investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but without diabetes. Researchers Thinking about stopping a GLP-1

I'm trying to get ahead of my condition by learning more about the latest research and drugs available." "I've been diagnosed with type 2 diabetes since 2000

In addition, studies suggest that asparagus spears have some antimicrobial properties, which may help protect against certain infections

doi: 10.1126/science.aau6977

In these scenarios, a higher-dose B12 supplement (typically 502,000 micrograms daily) or prescribed treatment may be necessary to restore and maintain adequate levels

arrow_forward Our team did extensive research into all available weight loss medications

Heart Disease and Kidney Health Heart disease and chronic kidney disease (CKD) are closely connected, and having one condition may increase your risk for the other